Extractables and leachables - Product Packaging Interaction studies
There is an expectation placed on companies operating in the global pharmaceutical, healthcare and medical device sectors to ensure they fully understand the potential interaction between their dosage form and the associated primary closure, and transfer system employed. LGC design and implement bespoke Product Packaging Interaction (PPI) studies.
Download the Product Packaging Interaction fact sheet to find out more about:
- Examples of regulatory concerns for common classes of drug products
- Overview of a typical extractables and leachables programme
- PPI study protocol
Complete the form to access your copy